- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- AH2: 1-deoxy-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:S.12, A:S.12, A:W.357, A:D.358
- Water bridges: A:R.353, A:R.353, A:R.359
- Salt bridges: A:R.353
SO4.5: 5 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
- Ligands: EDO.8
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:W.228
- Water bridges: A:K.79, A:K.79, A:H.306
- Salt bridges: A:K.79, A:R.277, A:H.306
SO4.12: 5 residues within 4Å:- Chain A: G.193, K.194, S.242, G.243, Y.244
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.194, A:G.243
- Water bridges: A:K.194
SO4.32: 6 residues within 4Å:- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:S.12, B:S.12, B:S.356, B:W.357, B:D.358
- Water bridges: B:R.353, B:R.353, B:D.358
- Salt bridges: B:R.353
SO4.34: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:W.228
- Water bridges: B:K.79, B:K.79, B:K.79, B:R.277, B:R.277, B:H.306, B:H.306
- Salt bridges: B:K.79, B:R.277, B:H.306
SO4.44: 8 residues within 4Å:- Chain B: G.265, L.268, A.269, H.274, V.276, R.277, L.278, Y.304
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:H.274, B:L.278, B:Y.304
SO4.47: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.194, B:G.243
SO4.48: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Y.487
- Salt bridges: B:R.44
- 2 x UUH: (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol(Covalent)
UUH.4: 30 residues within 4Å:- Chain A: R.120, D.127, F.128, W.179, N.234, E.235, L.241, Y.244, F.246, H.311, Y.313, L.314, F.316, E.340, C.342, S.345, K.346, W.348, W.381, N.396, V.398
- Chain B: L.241, Y.244, Y.313, L.314, F.316, W.348
- Ligands: EDO.19, UUH.33, EDO.51
14 PLIP interactions:12 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.241, A:Y.313, A:L.314, A:F.316, A:E.340, B:L.241, B:L.314
- Hydrogen bonds: A:D.127, A:W.179, A:N.234, A:E.340, A:W.381, A:N.396
- pi-Stacking: A:Y.313
UUH.33: 18 residues within 4Å:- Chain B: R.120, C.126, D.127, F.128, W.179, N.234, E.235, F.246, H.311, Y.313, E.340, C.342, S.345, W.381, N.396, V.398
- Ligands: UUH.4, EDO.51
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:Y.313, B:E.340
- Hydrogen bonds: B:D.127, B:W.179, B:N.234, B:E.340, B:W.381, B:N.396
- Water bridges: B:E.235
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 3 residues within 4Å:- Chain A: T.138, H.145, N.146
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.138
NAG.35: 3 residues within 4Å:- Chain B: T.138, H.145, N.146
No protein-ligand interaction detected (PLIP)NAG.45: 3 residues within 4Å:- Chain B: N.270, S.271, T.272
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.270
- Water bridges: B:N.270
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 11 residues within 4Å:- Chain A: R.2, P.3, C.4, D.24, S.25, F.26, R.48, M.49, G.113, K.413, Y.418
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: K.77, K.79, H.306, M.335, V.376
- Ligands: SO4.5
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: F.75, L.372, Y.373, H.374, R.433
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: L.165, A.168, R.170, P.171, V.172
- Ligands: UUE.26
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: R.44, S.45, Y.487
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: T.183, W.184, K.186, G.189, K.198
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain A: T.187, K.198, G.199, Y.205
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: E.254, R.257
- Ligands: EDO.28
Ligand excluded by PLIPEDO.16: 9 residues within 4Å:- Chain A: G.265, L.268, A.269, H.274, V.276, R.277, L.278, Y.304
- Ligands: EDO.17
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: R.277, A.302, K.303, Y.304, V.305, H.306
- Ligands: EDO.16
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain A: R.131, Y.133, T.134, Y.135, D.137, P.150
Ligand excluded by PLIPEDO.19: 9 residues within 4Å:- Chain A: E.235, S.237, A.238, Y.244, D.283, Q.284
- Chain B: F.316, L.317
- Ligands: UUH.4
Ligand excluded by PLIPEDO.20: 11 residues within 4Å:- Chain A: L.286, L.287, H.290, W.291
- Chain B: L.286, L.317, A.318, P.319, A.322, T.323
- Ligands: EDO.21
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain A: L.286, L.287, L.288, P.289, H.290, K.293
- Chain B: P.289
- Ligands: EDO.20
Ligand excluded by PLIPEDO.22: 12 residues within 4Å:- Chain A: R.285, V.310, H.311, W.312, D.315, L.324, A.338, S.366, N.370, V.375, W.378
- Ligands: EDO.23
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain A: R.285, W.312, D.315, H.365, S.366, T.369, N.370
- Ligands: EDO.22
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: L.91, N.92, A.95, N.386, P.391, I.406
Ligand excluded by PLIPEDO.25: 4 residues within 4Å:- Chain A: A.476, V.477, R.496, Q.497
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain A: A.261, R.262, P.266, E.300, K.303, Y.304
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: T.252, E.254, H.255
- Ligands: EDO.15, EDO.29
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain A: S.196, G.199, Q.200, P.201, H.255
- Ligands: EDO.28
Ligand excluded by PLIPEDO.30: 3 residues within 4Å:- Chain A: N.270, S.271, T.272
Ligand excluded by PLIPEDO.31: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPEDO.36: 8 residues within 4Å:- Chain B: P.3, C.4, D.24, G.46, R.47, R.48, E.50
- Ligands: EDO.37
Ligand excluded by PLIPEDO.37: 11 residues within 4Å:- Chain B: R.2, P.3, C.4, D.24, S.25, F.26, R.48, M.49, K.413, Y.418
- Ligands: EDO.36
Ligand excluded by PLIPEDO.38: 2 residues within 4Å:- Chain B: K.106, L.167
Ligand excluded by PLIPEDO.39: 7 residues within 4Å:- Chain B: L.91, N.92, A.95, N.386, P.391, V.404, I.406
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain B: S.12, R.44, S.45, Y.487
Ligand excluded by PLIPEDO.41: 8 residues within 4Å:- Chain B: R.39, E.41, R.47, S.52, T.482, I.483, P.485, H.490
Ligand excluded by PLIPEDO.42: 7 residues within 4Å:- Chain B: F.31, P.32, S.38, S.455, L.493, W.494, R.495
Ligand excluded by PLIPEDO.43: 6 residues within 4Å:- Chain B: D.453, G.454, S.455, R.495, R.496, Q.497
Ligand excluded by PLIPEDO.46: 3 residues within 4Å:- Chain B: L.94, P.98, Q.101
Ligand excluded by PLIPEDO.49: 2 residues within 4Å:- Chain B: E.254, R.257
Ligand excluded by PLIPEDO.50: 5 residues within 4Å:- Chain B: L.296, F.331, P.332, N.333, T.334
Ligand excluded by PLIPEDO.51: 6 residues within 4Å:- Chain A: W.348
- Chain B: K.346, F.347, W.348
- Ligands: UUH.4, UUH.33
Ligand excluded by PLIP- 1 x UUE: 8-[4-(1-ethyl-1,2,3-triazol-4-yl)butyl]-2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaene(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- van der Gracht, D. et al., Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases. Chem Sci (2023)
- Release Date
- 2022-03-30
- Peptides
- Lysosomal acid glucosylceramidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBB
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.86 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG- AH2: 1-deoxy-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 2 x UUH: (1~{S},2~{R},3~{R},4~{S},5~{S})-4-[[4-[4-[2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaen-8-yl]butyl]-1,2,3-triazol-1-yl]methyl]cyclohexane-1,2,3,5-tetrol(Covalent)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x UUE: 8-[4-(1-ethyl-1,2,3-triazol-4-yl)butyl]-2,2-bis(fluoranyl)-4,6,10,12-tetramethyl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.0^{3,7}]dodeca-1(12),4,6,8,10-pentaene(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- van der Gracht, D. et al., Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases. Chem Sci (2023)
- Release Date
- 2022-03-30
- Peptides
- Lysosomal acid glucosylceramidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
BBB